The 'London Patient' goes into HIV remission: Here's what that means
The 'London Patient' saw his HIV go into remission after receiving a bone marrow transplant in which the blood had a mutation that did not allow HIV to multiply. (Source: ABC News: Health)
Source: ABC News: Health - March 8, 2019 Category: Consumer Health News Tags: Health Source Type: news

A Man May Be Cleared of HIV for the Second Time in History. Here ’s What That Means
A man in London has become only the second person to achieve remission from HIV infection, researchers from the UK reported Tuesday. The therapy responsible has worked on only one other person who is considered to be “cured” of HIV: Timothy Ray Brown, who still does not show signs of the virus in his body after more than 10 years. Here’s what to know about the landmark case. How did it happen? In a letter published in the journal Nature, researchers led by Ravindra Gupta from the University of Cambridge London and Imperial College London and his colleagues say that they used a treatment similar to the one...
Source: TIME: Health - March 5, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized HIV/AIDS Source Type: news

Bone Marrow Transplant Renders Second Patient Free Of HIV
British doctors report the apparent eradication of HIV from a patient who was undergoing treatment for cancer. It's only the second time this has been accomplished, despite many attempts.(Image credit: SCIENCE SOURCE) (Source: NPR Health and Science)
Source: NPR Health and Science - March 5, 2019 Category: Consumer Health News Authors: Richard Harris Source Type: news

WATCH: Man possibly cured of HIV: Report
The findings in the journal Nature say the anonymous patient went into long-term remission from HIV during the process of a bone marrow transplant to treat cancer in 2016. (Source: ABC News: Health)
Source: ABC News: Health - March 5, 2019 Category: Consumer Health News Tags: GMA Source Type: news

First man cleared of HIV by stem cell treatment speaks of hope for others - video
The first known case of a functional cure for HIV happened 12 years ago, after US resident Timothy Brown received stem cell donations in Berlin. More recently, a patient in London received a bone marrow transplant from a virus-resistant donor and has been shown to be cleared of the virusContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 5, 2019 Category: Science Tags: Aids and HIV Medical research Health London UK news Society US news Science Source Type: news

‘London Patient’ Appears to Become the Second Person Ever Cured of AIDS
Doctors say a British man who previously tested positive for HIV might be the second person ever to be cured of the AIDS virus. Reuters reports that the man, whose identity has not been revealed, has tested negative for the virus almost three years after he received a bone marrow transplant from a donor with an HIV-resistant genetic mutation. The man stopped taking antiretroviral drugs 18 months ago. “There is no virus there that we can measure. We can’t detect anything,” Ravindra Gupta, the doctor who co-lead the man’s treatment team, told Reuters. The man, who has been dubbed the “London pat...
Source: TIME: Health - March 5, 2019 Category: Consumer Health News Authors: Amy Gunia Tags: Uncategorized health HIV/AIDS onetime overnight Source Type: news

‘London Patient’ Appears to Become the Second Person Ever Cured of HIV
Doctors say a British man who previously tested positive for HIV might be the second person ever to be cured of the virus that causes AIDS. Reuters reports that the man, whose identity has not been revealed, has tested negative for the virus almost three years after he received a bone marrow transplant from a donor with an HIV-resistant genetic mutation. The man stopped taking antiretroviral drugs 18 months ago. “There is no virus there that we can measure. We can’t detect anything,” Ravindra Gupta, the doctor who co-lead the man’s treatment team, told Reuters. The man, who has been dubbed the &ldqu...
Source: TIME: Health - March 5, 2019 Category: Consumer Health News Authors: Amy Gunia Tags: Uncategorized health HIV/AIDS onetime overnight Source Type: news

Tests on London patient offer hope of HIV 'cure'
Man becomes second person in world to be cleared of virus after stem cell donationA man in Britain has become the second known adult worldwide to be cleared of HIV after he received a bone marrow transplant from a virus-resistant donor, his doctors said.Almost three years after receiving bone marrow stem cells from a donor with a rare genetic mutation that resists HIV infection – and more than 18 months after he came off antiretroviral drugs – highly sensitive tests still show no trace of the man’s previous HIV infection.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 5, 2019 Category: Science Authors: Reuters Tags: Aids and HIV Society Health Medical research London UK news Science Source Type: news

Tests on London patient offer hope of HIV ‘cure’
Man becomes second person in world to be cleared of virus after stem cell donationA London patient with HIV has become the second person ever to be free of the virus after a bone marrow transplant, raising hopes of a cure for Aids.More than a decade ago, Timothy Brown, the so-called Berlin patient who later went public, made history as the first person to be “cured” of HIV. Like the London patient, he had a bone marrow stem cell transplant to treat cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 5, 2019 Category: Science Authors: Sarah Boseley Tags: Aids and HIV Society Health Medical research London UK news Science Source Type: news

London HIV patient becomes world's second AIDS cure hope
An HIV-positive man in Britain has become the second known adult worldwide to be cleared of the AIDS virus after he received a bone marrow transplant from an HIV resistant donor, his doctors said. (Source: Reuters: Health)
Source: Reuters: Health - March 5, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Three Ways to Address BMT Patients in Community Three Ways to Address BMT Patients in Community
Moving to community care may imperil blood and bone marrow transplant patients. Three nurse-led studies show how the challenge can be met.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 26, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Sick kids left in limbo by Venezuela-US crisis
When Carlos Acosta was able to fly his son out of a Venezuela that lacked basic medical supplies and see him receive a bone marrow transplant in Spain, it was as if his prayers had been answered (Source: ABC News: Health)
Source: ABC News: Health - February 23, 2019 Category: Consumer Health News Tags: Health Source Type: news

Only on AP: Sick kids left in limbo by Venezuela-US crisis
When Carlos Acosta was able to fly his son out of a Venezuela that lacked basic medical supplies and see him receive a bone marrow transplant in Spain, it was as if his prayers had been answered (Source: ABC News: Health)
Source: ABC News: Health - February 23, 2019 Category: Consumer Health News Tags: Health Source Type: news

Severely ill children left in limbo by Venezuela-US crisis
When Carlos Acosta was able to fly his son out of a Venezuela that lacked basic medical supplies and see him receive a bone marrow transplant in Spain, it was as if his prayers had been answered (Source: ABC News: Health)
Source: ABC News: Health - February 23, 2019 Category: Consumer Health News Tags: Health Source Type: news

A bioengineered factory for T-cells
(Harvard John A. Paulson School of Engineering and Applied Sciences) Harvard engineers and stem cell biologists have developed an injectable sponge-like gel that enhances the production T-cells after a bone marrow transplant. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2019 Category: International Medicine & Public Health Source Type: news

A family ’s $1.6 million fight against cancer
The Jacquie Hirsch For A.L.L. Foundation works to promote awareness and testing for bone marrow transplants in the hopes of helping people with bone cancer find a match. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 7, 2019 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Cellect Biotechnology launches U.S. clinical trial
Cellect Biotechnology (NSDQ:APOP) said it is collaborating with Washington University on a study of its ApoGraft stem cell selection technology for bone marrow transplantations. This will be the first clinical trial in the U.S. using Tel Aviv, Israel-based Cellect’s ApoGraft, which is designed to prevent acute graft-versus-host disease following bone marrow transplantation. The company previously reported positive safety and tolerability data from an ongoing trial that is being performed outside the U.S., and expects to report additional interim results during the first half of 2019. Get the full ...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Clinical Trials News Well Oncology Regenerative Medicine cellectbiotechnology Washington University School of Medicine Source Type: news

New therapeutic target for graft-vs-host disease could make bone marrow transplant safer
(Medical University of South Carolina) Graft-versus-host disease (GVHD) is a major complication of bone marrow transplant, a potentially curative treatment for patients with blood-borne cancers such as leukemia and lymphoma. Inhibiting Sirt-1 in a mouse model helped control GVHD without making tumor relapse more likely, report researchers at the Medical University of South Carolina in Blood. The inhibitor has already been proven safe in humans but would need further testing in patients with blood-borne cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 25, 2019 Category: Cancer & Oncology Source Type: news

Addition of BMT Not Indicated in Some With Peds Hypodiploid ALL
Bone marrow transplant not beneficial if no minimal residual dz after remission induction tx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 23, 2019 Category: Cancer & Oncology Tags: Oncology, Pediatrics, Journal, Source Type: news

Actinium Pharmaceuticals Appoints Accomplished Industry Executive Cynthia Pussinen as Executive Vice President of Technical Operations and Supply Chain
Senior hire adds 25 years of highly relevant leadership, technical operations and supply chain experience from Pfizer and Ipsen to Actinium's Executive Team Ms. Pussinen to lead technical and supply chain efforts to drive forward Actinium's multi-diseas... Biopharmaceuticals, Oncology, Personnel Actinium Pharmaceuticals, Iomab-B, bone marrow transplant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2019 Category: Pharmaceuticals Source Type: news

Scientists learn how common virus reactivates after transplantation
(Fred Hutchinson Cancer Research Center) A new study in Science challenges long-held theories of why a common virus -- cytomegalovirus, or CMV -- can reactivate and become a life-threatening infection in people with a compromised immune system, including blood cancer patients undergoing bone marrow transplantation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Young dad thanks blood donors who saved his life
As Tyler Bacon gripped the lectern in Carnesale Commons and scanned the crowd gazing at him expectantly, he struggled to hold back tears.The 39-year-old father of two from Thousand Oaks was finally meeting some of the more than two dozen people whose blood and platelet donations sustained his life during cancer treatment at  Ronald Reagan UCLA Medical Center.  “Because you showed up and donated, my parents still have a son,” Bacon said. “My children have a dad. My wife has a husband.”His voice quaking with emotion, he added, “All the gratitude in the world would not be enough to say ...
Source: UCLA Newsroom: Health Sciences - January 17, 2019 Category: Universities & Medical Training Source Type: news

Father of two thanks blood donors who saved his life
As Tyler Bacon gripped the lectern in Carnesale Commons and scanned the crowd gazing at him expectantly, he struggled to hold back tears.The 39-year-old father of two from Thousand Oaks was finally meeting some of the more than two dozen people whose blood and platelet donations sustained his life during cancer treatment at  Ronald Reagan UCLA Medical Center.  “Because you showed up and donated, my parents still have a son,” Bacon said. “My children have a dad. My wife has a husband.”His voice quaking with emotion, he added, “All the gratitude in the world would not be enough to say ...
Source: UCLA Newsroom: Health Sciences - January 16, 2019 Category: Universities & Medical Training Source Type: news

UCLA researchers correct genetic mutation that causes IPEX, a life-threatening autoimmune syndrome
UCLA researchers led by Dr. Donald Kohn have created a method for modifying blood stem cells to reverse the genetic mutation that causes a life-threatening autoimmune syndrome called IPEX. The gene therapy, which was tested in mice, is similar to the technique Kohn has used to cure patients with another immune disease, severe combined immune deficiency, or SCID, also known as bubble baby disease.The workis described in a study published in the journal Cell Stem Cell.IPEX is caused by a mutation that prevents a gene called FoxP3 from making a protein needed for blood stem cells to produce immune cells called regulatory T ce...
Source: UCLA Newsroom: Health Sciences - January 10, 2019 Category: Universities & Medical Training Source Type: news

Stem cell study offers clues for optimizing bone marrow transplants and more
Bone marrow transplants, which involve transplanting healthy blood stem cells, offer the best treatment for many types of cancers, blood disorders and immune diseases. Even though 22,000 of these procedures are performed each year in the US, much remains to be understood about how they work. (Source: World Pharma News)
Source: World Pharma News - January 9, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Stem cell study offers clues for optimizing bone marrow transplants and more
(University of Southern California - Health Sciences) A new USC and Stanford study, conducted in mice, shows that successfully transplanted stem cells don't behave 'normally' as in a healthy person without a transplant. Instead, the radiation and high-dose chemotherapy used to wipe out diseased stem cells prior to transplantation appear to trigger 'extreme behavior' in the newly transplanted cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2019 Category: International Medicine & Public Health Source Type: news

New stem cell treatment uses umbilical cord blood for bone marrow patients
A treatment that uses stem cells from umbilical cord blood could be safe for bone marrow transplant patients, a study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 5, 2018 Category: Consumer Health News Source Type: news

Expanded cord blood shows potential for use in adult bone marrow transplants
(Duke University Medical Center) Umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Pregnant mother-of-3 desperately searches for bone marrow donor after 30 million failed matches
Susie Rabaca, 36, is a mother of three, pregnant with twins and dying of leukemia. She needs a bone marrow transplant, finding a match is difficult simply because Rabaca is mixed-race. a (Source: the Mail online | Health)
Source: the Mail online | Health - November 25, 2018 Category: Consumer Health News Source Type: news

Father, 35, survived cancer as a teenager thanks to his brother's bone marrow transplant
Harry Page, from New Jersey, US, had acute myeloid leukaemia when he was 19 years old and survived thanks to a bone marrow transplant from his brother, Ryan, who then died in 2006. (Source: the Mail online | Health)
Source: the Mail online | Health - November 21, 2018 Category: Consumer Health News Source Type: news

New research on CAR T cell therapy, bone marrow transplants and blood cancer treatments
(City of Hope) City of Hope announced today that it will present data on new findings on immunotherapies, including CAR T cell therapy, bone marrow transplants and other treatments for blood cancers, at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4 in San Diego. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 16, 2018 Category: Cancer & Oncology Source Type: news

Duke University Hospital seeking $18.2M renovation
Duke University Health System is asking the state of North Carolina for permission to begin an $18.2 million overhaul on part of its main campus.   This week, the N.C. Department of Health and Human Services released an application petitioning for a certificate of need that would allow for the renovations at Duke University Hospital.  According to NCDHHS, the project would renovate the north pavilion at the hospital for the system’s adu lt bone marrow transplant services and a combined hematologic… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 15, 2018 Category: Biotechnology Authors: Seth Gulledge Source Type: news

$2.4M bequest: Children's to name part of new building for executive, wife
Cincinnati Children ’s Hospital plans to name the Bone Marrow Transplant Unit in the Critical Care Building now under construction in honor of the late Mary and Joseph Stern Jr., who recently left $2.4 million to the medical center. Mary Stern died in June at age 97. Joseph Stern, who had been president and chairman of U.S. Shoe Corp. as well as a trustee of Cincinnati Children’s, died in 2010 at age 91. At the time he died, the Hematology and Oncology Research Center at the hospital was named… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 31, 2018 Category: American Health Authors: Barrett J. Brunsman Source Type: news

Tandem Lung-Bone Marrow Transplant Shows Promise
(MedPage Today) -- Protocol being used in patients with primary immunodeficiencies (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 9, 2018 Category: Respiratory Medicine Source Type: news

Decades later, man meets the UCLA doctor who saved his life
It ’s 1970 and 10-month-old Maurice Elias lay in a hospital bed in the pediatric intensive care unit dangerously malnourished, at just 14 pounds, and with a severe infection in his mouth. The antibiotics that doctors at UCLA had been using to treat Maurice, who had been born without a functional immu ne system, were no longer working.The only way Maurice was going to survive was a bone marrow transplant.“If we couldn't find a way to give Maurice a working immune system, he was going to die. And the only way to do so was with a risky transplant that could be fatal, too,” said Dr. Richard Stiehm, the UCLA d...
Source: UCLA Newsroom: Health Sciences - September 19, 2018 Category: Universities & Medical Training Source Type: news

Cancer survivor, 11, shares photo of the moment after her bone marrow transplant
Alex Duffin, now 15, underwent an extraction at Connecticut Children's Hospital in September 2014. After nine months in recovery, Emma was given the all clear - and remains in remission four years on. (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2018 Category: Consumer Health News Source Type: news

Stowers breakthrough could make stem cells available where bone marrow matches aren't
A new discovery by the Stowers Institute of Medical Research could make more resources available to patients who might not have a bone marrow transplant match available. In cases where a patient with leukemia or a blood disorder doesn't have a bone marrow match, blood-forming adult stem cells from the umbilical cord can be transplanted. Just 30 percent of patients have a donor match in their family. However, adult patients need about two cords' worth for treatmen t, meaning there aren't enough available… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 6, 2018 Category: Biotechnology Authors: Elise Reuter Source Type: news

Stowers breakthrough could make stem cells available where bone marrow matches aren't
A new discovery by the Stowers Institute of Medical Research could make more resources available to patients who might not have a bone marrow transplant match available. In cases where a patient with leukemia or a blood disorder doesn't have a bone marrow match, blood-forming adult stem cells from the umbilical cord can be transplanted. Just 30 percent of patients have a donor match in their family. However, adult patients need about two cords' worth for treatmen t, meaning there aren't enough available… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 6, 2018 Category: American Health Authors: Elise Reuter Source Type: news

Pediatric Bone Marrow Transplant Ups Early Mortality Risk for Decades Pediatric Bone Marrow Transplant Ups Early Mortality Risk for Decades
Recipients of donor blood or marrow transplants (BMTs) during childhood remain at increased risk of premature death for 25 years or more after the procedure, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 4, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Solution to medical mystery may help some children avoid bone marrow transplantation
(St. Jude Children's Research Hospital) Researchers have helped solve a decades-old mystery about which mutations are responsible for an inherited bone marrow disorder. The answer may allow some children to avoid the risk and expense of bone marrow transplantation, a common treatment for leukemia and bone marrow disorders. Investigators at St. Jude Children's Research Hospital and UCSF, led the study, which appears today in the scientific journal JCI Insight.The disorder is myelodysplasia and leukemia syndrome with monosomy 7. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 26, 2018 Category: Biology Source Type: news

PIM-2 protein kinase regulates T-cell activity differently than PIM-1 or PIM-3 isoform
(Medical University of South Carolina) The PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity, while PIM-1 and PIM-3 are positive regulators, report Medical University of South Carolina investigators in The Journal of Clinical Investigation. Blocking PIM-2 in allogeneic bone marrow transplant dramatically accelerated graft-versus-host disease. In adoptive immunotherapy with autologous T cells, silencing PIM-2 on T cells produced robust tumor immunity, highlighting the importance of PIM-specific inhibition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

Girl, 6, bravely battles two types of rare cancer and needs bone marrow transplant
Kalea Ramos, six, from San Diego, California, was diagnosed with two forms of rare leukemia last October, leaving her in need of a bone marrow transplant - and nobody in her family is a match. (Source: the Mail online | Health)
Source: the Mail online | Health - May 29, 2018 Category: Consumer Health News Source Type: news

The Healing Edge: Five Blood Transfusions, One Bone Marrow Transplant — All Before Birth
In a bold experiment in fetal therapy, doctors in San Francisco treated a fetus with a severe, often fatal blood disorder. The child was saved, but the long-term prognosis is still uncertain. (Source: NYT Health)
Source: NYT Health - May 25, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Transfusions Pregnancy and Childbirth Bone Marrow Genetics and Heredity Immune System University of California, San Francisco Source Type: news

New CAR T case study shows promise in acute myeloid leukemia
(H. Lee Moffitt Cancer Center& Research Institute) According to a case study from trial published online ahead of print in the journal Haematologica, a patient has remained cancer free for nine months after being treated with CYAD-01, followed by a bone marrow transplant. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2018 Category: Cancer & Oncology Source Type: news

Latest Mesothelioma Immunotherapy Combination Looks Promising
Scientists at the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital have uncovered a novel, two-agent immunotherapy combination that worked surprisingly well in animal models with malignant mesothelioma. The discovery has sparked new optimism for immunotherapy, which has struggled to provide consistently positive results with aggressive cancers such as mesothelioma. “This is the beginning of a new story of hope, a new combination of immunotherapy,” Dr. Mark Poznansky, director of the VIC and associate professor at Harvard Medical School, told Asbestos.com. “It worked quite well in a...
Source: Asbestos and Mesothelioma News - April 17, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Uncovering a mechanism causing chronic graft-vs-host disease after bone marrow transplant
(Medical University of South Carolina) MicroRNA-17-92 is required for the T-cell and B-cell pathogenicity that drives chronic graft-versus-host disease (cGVHD) after allogeneic bone marrow transplant (BMT), report investigators at The Medical University of South Carolina in an article prepublished online March 12, 2018 by Blood. Data from cGVHD mouse models showed that, by determining T-cell and B-cell differentiation and function, miR-17-92 is responsible for cGVHD development. Inhibiting miR-17 is a potential therapeutic strategy for preventing cGVHD in BMT patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 2, 2018 Category: Cancer & Oncology Source Type: news

Iranian man granted visa to donate bone marrow to brother in US
After almost two months, the US State Department approved a visa for an Iranian man to come to the United States in order to have bone marrow transplant surgery to help his brother, who has cancer. (Source: CNN.com - Health)
Source: CNN.com - Health - March 30, 2018 Category: Consumer Health News Source Type: news

Trump's Travel Ban Imperils U.S. Citizen With Cancer Trump's Travel Ban Imperils U.S. Citizen With Cancer
Maziar Hashemi, a naturalized U.S. citizen who lives in Massachusetts, has been told by doctors that his best hope for surviving a rare form of blood cancer is a bone marrow transplant.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 30, 2018 Category: Transplant Surgery Tags: Public Health & Prevention News Source Type: news